the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
Naltrexone has been studied across 18 research domains including 💊 Pain, 🫁 Liver & Detox, 🌤️ Mood & Depression, 😴 Sleep, 🔥 Metabolic. The primary research focus is 💊 Pain with 35% of studies addressing this area.
This evidence profile for Naltrexone is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.